Drugs / KPC000154
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06867406 | Mar → Nov 2025 overdue | low density lipoprotein cholesterol, mild elevation of | Kunming Pharmaceuticals, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KPC000154 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06867406 ↗ |
| Route | Oral | “KPC000154 10mg Tablet administered orally” NCT06867406 ↗ |